Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Halozyme Therapeutics Inc (NASDAQ:HALO)

11.50
Delayed Data
As of Jan 20
 +0.42 / +3.79%
Today’s Change
6.96
Today|||52-Week Range
14.38
+16.40%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.5B

Company Description

There is no company description available for Halozyme Therapeutics Inc.

Contact Information

--
--
-- -- --
P:
Investor Relations:
--

Employees

Shareholders

Mutual fund holders46.23%
Other institutional21.93%
Individual stakeholders21.79%

Top Executives

There are no executives to display.